Category Archives: oud

Integrated Device Tech’s ZMDI Buy To Sweeten 2017 EPS

Integrated Device Technology’s (IDTI) $310 million ZMDI acquisition will sweeten the chipmaker’s fiscal 2017 earnings per share to the tune of 10 cents — well above Wall Street expectations, Craig-Hallum analyst Anthony Stoss wrote Tuesday. In a research report, Stoss hiked his price target on Integrated Device stock to 33 from 30 and reiterated a buy rating. He also increased his earnings per share ex items forecast for fiscal 2017 ending March

3 Big Pharma Upgrades (And One Downgrade) At Barclays

Big pharmas Merck (MRK), Eli Lilly (LLY) and Johnson & Johnson (JNJ) were trading up Tuesday after getting upgrades from Barclays, while AbbVie (ABBV) seesawed on a downgrade. Analyst Geoff Meacham assumed coverage of a newly combined U.S. Pharmaceuticals sector in Barclays’ coverage, and while he left most ratings the same he made a few tweaks. Lilly was upgraded to overweight from equal weight, and its price target lifted to 95 from 75, based on

Get Ready For Alphabet Stock To Hit $1,000: Analyst

Strong holiday shopping results — coupled with a bullish report on Tuesday from RBC Capital Markets — helped push Alphabet (GOOGL) stock to an all-time high. Alphabet stock was up 2.8% in afternoon trading in the stock market today, near 784. Shares of Google-owner Alphabet have risen more than 45% this year. The stock is 10% extended from a 713.43 buy point touched Oct. 23. RBC analyst Mark Mahaney gave a “share price potential” of 1,000 for